Trial intelligence / Profile preview

Bioequivalence of Guaifenesin and Pseudoephedrine ER vs Mucinex D

NCT03706300Phase 1Completed

Sponsor
Dr. Reddy's Laboratories
Start
Dec 2014
Primary completion
Jan 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised, open-label trial of guaifenesin and pseudoephedrine in common cold and nasal congestion (2 arms), sponsored by Dr. Reddy's Laboratories. Primary endpoint: Area under curve. Started Dec 2014; status: completed.

02

Drugs

guaifenesinpseudoephedrine
03

Conditions

common coldnasal congestion

Beyond the preview

Go deeper on NCT03706300.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03706300.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call